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Abstract
Background: We report an unusual case of a 66-year-old female with a suspicious thoracic outlet mass presenting
with severe biochemical hyperparathyroidism and classic hypercalcemic symptoms of renal and bone involvement.
Case Presentation: There was clinical suspicion for parathyroid carcinoma, further supported by intra-operative
findings. However, the final pathology described a primary hyperceullar parathyroid lesion with pathognomonic
changes secondary to fine-needle aspiration (FNA) biopsy, along with a separate parathyroid lesion likely resulting
from seeding along the needle tract. Upon further review, record of a remote FNA was discovered. This case
highlights the complications associated with parathyroid FNA resulting in a diagnostic challenge and raising the
possibility of malignancy.
Conclusions: We therefore recommend to take caution when there is a prior parathyroid FNA, as it can present
with the risks of a secondary lesion from seeding and increase resemblance of malignancy both clinically and
through pathologic diagnosis.
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Background
Ultrasound-guided fine needle aspiration (FNA) can be
performed to localize a parathyroid lesion and distin-
guish parathyroid tissue from surrounding structures [1].
However, there are several innate risks of this procedure
that can cause difficulties in diagnosis and management.
Specifically, parathyroid adenomas with previous FNA
have the risk of a fibrotic reaction leading to adhesions
to surrounding structures and histological alterations re-
sembling malignancy [2, 3]. Another potential risk of
FNA biopsy is tumor seeding along the needle tract, as
parathyroid tissue can adhere to and grow in various set-
tings, explaining the high success with autotransplanta-
tions [4–6]. Due to these complications and the limited
utility of FNA in typical cases of parathyroid lesions, we
would like to encourage caution on interpreting clinical
and pathologic diagnoses for cases with a prior FNA.
We report a patient with a six-year history of a slowly
enlarging cystic neck mass initially thought to be a be-
nign lymphangioma involving the thoracic outlet. She
developed characteristics of parathyroid carcinoma: a
palpable neck mass, severe hyperparathyroidism and
hypercalcemic symptoms of renal and bone involvement.
The lesion was surgically excised and confirmed to be a
parathyroid adenoma with extensive fibrosis and cystic
degeneration. There was also a separate parathyroid lesion
likely resulting from seeding along the needle tract. On
careful record review, a report of a previous radiology-
directed FNA at an external institution was identified that
the patient was unable to recall. Furthermore, there was
periprocedural hemolysis and severe ecchymosis that
required close observation in the radiology suite. This case
emphasizes the complications of fibrosis and seeding
secondary to parathyroid FNA.
Case Presentation and Conclusion
An otherwise healthy 66-year-old female presented to
her family physician with two episodes of hypercalcemia
and associated symptoms of fatigue, confusion, visual
changes and constipation. Her previous medical history
was positive for nephrolithiasis and a long-standing cys-
tic neck mass. This was suspected to be a benign lym-
phangioma involving the left thoracic outlet, and was
followed conservatively by thoracic surgery since 2010.
Her bone mass density decreased by over 17% from
2012 to 2014. She was sent to the emergency room
where she had a corrected serum calcium (Ca) of 4.54
(2.2–2.7) mmol/L and parathyroid hormone (PTH) of
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125 (1.2–5.8) pmol/L. She was admitted and stabilized
with IV pamidronate and fluids. She underwent a
sestamibi scan with single-photon emission computed
tomography (SPECT) showing increased activity in the
left cystic neck mass. Repeat investigations showed a
corrected Ca of 3.83 (2.2–2.7) mmol/L and normal thy-
roid function tests. Further investigations included a
computed tomography (CT) with IV contrast of the neck
and chest showing an enhancing solid and cystic lesion
posterior to the left thyroid with extension to the
anterior and superior mediastinum of 3.0 × 2.1 × 6.0 cm
(AP × TR × CC), juxtaposed between the innominate ar-
tery and left common carotid artery down to the aortic
arch (Fig. 1). There was no evidence of metastatic dis-
ease to the head and neck.
She underwent a left hemithyroidectomy, parathyroid-
ectomy, and modified radical neck dissection of levels
III, IV, VI, and VII. The trachea was deviated to the
right. Several lymph nodes appeared suspicious prompt-
ing the neck dissection. The mass adhered to the sur-
rounding structures and was carefully delineated from
the esophagus, trachea and recurrent laryngeal nerve
requiring microsurgical dissection. Intra-operative path-
ology consultation identified hypercellular parathyroid
tissue. A pretracheal mass in level VII thought to be
nodal was also resected. There were no complications.
She presented with a strong voice and cough post-
operatively with normal vocal cord movement on
fiberoptic nasopharyngoscopy. Post-operative PTH had
normalized at 4.3 (1.2–5.8) pmol/L and the corrected Ca
also normalized.
The final pathology showed two separate lesions com-
posed of similar parathyroid chief and clear cells. Both
lesions had extensive fibrosis radiating outwards, and
were filled with necrotic debris; there was associated
vascularity with hemorrhage and hemosiderin depos-
ition. The larger lesion had surrounding non-tumorous
parathyroid tissue that was normocellular. Both speci-
mens had the immunoprofile of non-malignant parathy-
roid tissue [7]: they stained for GATA-3 and parathyroid
hormone, and had intact reactivity for parafibromin,
BCL-2, p27 and RB; there was no expression of galectin-3.
Cyclin D1 was expressed in the majority of tumor cells, a
feature characteristic of parathyroid adenomas; staining
Fig. 1 Computed Tomography scan of the neck with IV contrast showing the primary parathyroid lesion and the separate supra-aortic parathyroid
lesion, likely secondary to seeding from FNA. a, b, c - Coronal view; d, e - Axial view. The normal thyroid gland is identified (a). The primary parathyroid
lesion, measuring 59.7 mm, is located posterior to the thyroid gland (b). The separate supra-aortic lesion likely secondary to seeding measures to be
14.6 mm (c). The primary parathyroid lesion measures 18.6 mm x 28.6 mm (d). The separate supra-aortic lesion localized in the pre-tracheal area
measures 12.6 mm x 15.8 mm (e)
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for p53 revealed only focal positivity. Ki-67 labelled only
about 2% of tumor cells. The thyroid was unremarkable
and all lymph nodes were negative for malignancy. The
features were consistent with a chief and clear cell aden-
oma with post-biopsy cystic degeneration and extensive
reactive changes (Fig. 2).
There are inherent risks of parathyroid pre-operative
biopsies that may alter a typical presentation. Specific-
ally, FNA of parathyroid lesions has the potential for
complicating diagnosis and management [1, 8]. Some of
the risks include disruption of the lesion and seeding
along the needle tract, causing separate secondary para-
thyroid lesions [4–6]. The dense fibrotic reaction that
may occur following FNA can complicate surgery by in-
creasing adhesions to surrounding structures such as the
recurrent laryngeal nerve resulting in less clear tumor
borders and increased operative time [2]. These features
resemble those of parathyroid carcinoma and can also
mislead the pathologist with reactive changes atypical
for parathyroid adenoma [3].
Due to the rare incidence of parathyroid carcinoma
compared to the more commonly seen parathyroid ad-
enoma, clinical suspicion is pertinent to plan appropriate
management [9]. Parathyroid carcinoma requires a more
extensive treatment plan than parathyroid adenoma,
with controversy regarding adjuvant radiation therapy.
As the presentation of both lesions are similar and para-
thyroid carcinoma is very rare, this poses a diagnostic
challenge. Pre-operatively, parathyroid carcinoma can be
expected based on factors including a larger tumor size,
palpable mass, severe primary hyperparathyroidism
(PTH 3–15 times the normal upper limit) and hypercal-
cemia (>3.5 mmol/L) often with renal and bone involve-
ment by the onset of presentation [9]. However, with
reactive changes secondary to FNA testing and risk of
seeding along the needle tract, these clinical and biochem-
ical differences between a benign and malignant presenta-
tion can be further masked making an even more
challenging diagnosis. This was illustrated in our case with
a large neck mass associated with hyperparathyroidism
resembling levels suspicious of malignancy, and hypercal-
cemic symptoms involving the kidneys and bone.
FNA is known to cause reactive changes seen on hist-
ology in the thyroid, salivary gland, breast tissue and
parathyroid. These reactive changes include fibrosis and
hemosiderin deposition in the chronic setting, and
Fig. 2 Pathology from the primary parathyroid lesion with FNA-related changes, and biomarker testing to confirm the absence of malignant
features. The parathyroid is well delineated but has a central scar; there is hemorrhage and focal cystic change (top left). The tumor is intensely
positive for Bcl-2 (top middle). Nuclear parafibromin is intact (top right). Staining identifies Rb in tumor cell nuclei (bottom left). Galectin-3 is not
seen in tumor cells; endothelial cells provide an internal positive control (bottom middle). Cyclin D1 is expressed by the majority of the tumor cell
nuclei (bottom right)
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hemorrhage in the acute setting. These features can
make it difficult to distinguish between benign and ma-
lignant tissue, and therefore histologically will often
present with a possibility of malignancy [2, 3]. The use
of biomarkers can help to make this distinction and
were used for our patient to confirm the absence of pro-
liferative and other proteomic features of malignacy [7].
In our case, specific post-biopsy changes were noted in
two tissues. It was unexpected that the second separate
lesion would also represent a parathyroid adenoma; we
interpret this as a product of seeding from the prior
FNA with concomitant histologic post-biopsy changes.
This finding is very interesting as it was not suspected
pre-operatively on imaging, where the focus was on the
prominent larger mass. Hence, when a patient presents
with a history of FNA, one must be cautious when the
pathologic diagnosis includes a possibility of malignancy
as well as being aware of additional discrete lesions that
may be secondary to seeding.
Our patient represents a very interesting and unusual
case of a parathyroid adenoma with two separate lesions
presenting biochemical, clinical and intra-operative fea-
tures resembling malignancy. The surprising benign out-
come on histologic examination confirming a parathyroid
adenoma with post-biopsy changes prompted this paper
to further expose the negative complications of FNA on
parathyroid lesions. As the FNA was completed prior to
hospital admission, we were required to search for a rec-
ord of this investigation to explain the final pathology re-
sults. We therefore discourage FNA of parathyroid lesions
and if a prior FNA was completed, we encourage caution
in the clinical assessment and pathologic interpretation as
there is an increased risk of a false-positive for malig-
nancy. In cases presenting with a prior FNA, awareness of
the possible fibrotic reaction, histologic alterations and
changes in biochemical presentation should be noted
when planning patient care.
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